Theravance Biopharma Inc (TBPH) — Cash Flow Reinvestment Rate
Theravance Biopharma Inc (TBPH) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting $36.29 Million (capex $34.00K plus investments $-36.26 Million) from operating cash flow of $208.07 Million. See TBPH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Theravance Biopharma Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Theravance Biopharma Inc across 1 annual periods. For the full cash flow conversion analysis, see TBPH cash flow conversion.
Annual Cash Flow Reinvestment Rate for Theravance Biopharma Inc (2025–2025)
Year-by-year capital reinvestment analysis for Theravance Biopharma Inc. See financial agility of Theravance Biopharma Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | $105.28 Million | $238.54 Million | $42.00K | — |